Biggest News Aggregation in the World
๐Ÿ“ฐ Anticancer Research News

Anticancer Research News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Anticancer Research. Real-time updates on events, politics, business and more.

Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous nonsmall cell lung cancer in TROPIONLung01 Phase III trial

Highlevel overall survival OS results from the TROPIONLung01 Phase III trial which previously met the dual primary endpoint of progressionfree survival PFS numerically favoured datopotamab deruxtecan DatoDXd compared to docetaxel in the overall trial population of patients with locally advanced or metastatic nonsmall cell lung cancer NSCLC treated with at least one prior line of therapy.
United States United Kingdom Ken Takeshita Ann Onc Susan Galbraith Adrian Kemp

Air pollution increases the risk of dying from breast cancer by 80% and is as dangerous as smoking, obesity and alcohol, research finds

EXCLUSIVE: While air pollution's link to lung conditions is well known, it's also directly implicated in cancer, including breast and prostate, according to the review of 27 studies.
United Kingdom Kefah Mokbel Anticancer Research On A Cancer Research United Kingdom Good Health Anticancer Research

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and AstraZenecaโ€™s datopotamab deruxtecan may be the first TROP2 directed antibody drug conjugate...
United States Ken Takeshita Susan Galbraith Ann Onc Daiichi Sankyo Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer

Application based on results from the TROPION-Lung01 Phase III trial If approved, AstraZeneca and Daiichi Sankyoโ€™s datopotamab deruxtecan may be the first TROP2-directed antibody drug conjugate...
United States United Kingdom Ann Onc Daiichi Sankyo Biologics Daiichi Sankyo Susan Galbraith

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science